1. Home
  2. ERNA

ERNA

Eterna Therapeutics Inc.

Logo Eterna Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
.
-
-
%

Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.

Founded: 2018 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 11.6M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 8.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -4.08 EPS Growth: N/A
52 Week Low/High: $0.84 - $3.75 Next Earning Date: 05-09-2024
Revenue: $68,000 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: